Immunotherapy Strategy against Ebola Virus: Presentation of Recent Researches during Ebola Meeting

Ebola is a highly fatal disease, for which no efficient therapy is available today. There is increasing evidence that transfusion of blood from patients recovered from EVD has therapeutic effect, most likely related to the presence of neutralising antibodies, opening the potential for immune therapy. A potential future topic would be aimed at developing therapeutic products for filovirus infections based on passive immunisation (such as monoclonals, hyperimmune gammaglobulines, etc...), which should result in sufficient treatment regimens available at affordable price. Major, Short and poster presentation will be discussed during Paris Ebola 2015.

For more information: www.targeting-ebola.com

TARGETING EBOLA WORLD CONGRESS WAS A HUGE SUCCESS